University of Michigan
Ann Arbor, MI, United States
Dinesh Khanna, MD, MSc, is the Frederick G.L. Huetwell Professor of Medicine and Director, University of Michigan Scleroderma Program. He is currently funded by the National Institutes of Heath with grants from NIAMS and NIAID (as part of Clinical Autoimmunity Center of Excellence). Dr Khanna has published over 550 peer-reviewed articles and book chapters. Dr Khanna is the Coordinating PI for ongoing and recently completed NIH and industry-funded trials in scleroderma. His current research is focused on validating outcome measures, trial design, and understanding the mechanism of action(s) of novel targets in the context of scleroderma clinical trials. He led the development of American College of Rheumatology Combined Response Index in Systemic Sclerosis (ACR CRISS) and Revised CRISS. Dr Khanna is recipient of the Henry Kunkel Young Investigator Award from the American College of Rheumatology.
Using the Systemic Autoimmune Rheumatic Disease-ILD Guidelines
Sunday, November 12, 2023
8:00 AM – 8:15 AM PT
Disclosure(s): AbbVie: DSMB (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Genentech: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing); Prometheus: Consultant (Ongoing)
1515: Performance of the Revised CRISS in a Phase 3 Trial of Early Systemic Sclerosis
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): AbbVie: DSMB (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Genentech: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing); Prometheus: Consultant (Ongoing)
